Bonesupport Holding AB specializes in the development and commercialization of orthobiologic products for the treatment of bone disorders. The company's proprietary technology platform, CERAMENT, is an injectable, synthetic bone graft substitute that naturally remodels into healthy host bone. Its product portfolio includes CERAMENT Bone Void Filler (BVF), as well as antibiotic-eluting variants like CERAMENT G (gentamicin) and CERAMENT V (vancomycin) which are designed to prevent bone infections such as osteomyelitis. Bonesupport primarily serves orthopedic surgeons and healthcare providers across North America, Europe, and other international markets. The company is headquartered in Lund, Sweden, and operates as a key player in the global bone graft substitute market.
